A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

NCT03733561 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: LY03003
DRUG: Neupro 4Mg/24Hr Transdermal Patch

Sponsor

Luye Pharma Group Ltd.